Discussion : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
We did not classify peri-implant diseases into peri-implant mucositis and peri-implantitis in this pilot study. Peri-implant mucositis does not show BL, whereas peri-implantitis shows BL of more than 2.5 or 3 mm on intra-oral radiographs [39, 40]. Figuero et al. [2] introduced plural diagnostic criteria for peri-implant mucositis and peri-implantitis. Rakic et al. [5] defined peri-implantitis as a PD of more than 5 mm, BOP positive, and BL of at least two threads of implant. Furthermore, Sanz et al. [41] proposed their opinion for the radiographic assessment of alveolar bone in peri-implant treatment. However, difficulties are associated with accurately measuring 2–3 mm of alveolar BL on a radiograph taken by a regular method and assessing BL levels by implant threads when implant species differ. We evaluated BL around dental implants using Schei et al.’s method [30], which has been used to evaluate BL rate in periodontal diseases. The mean BL rate was significantly higher at peri-implant disease site than at healthy sites without inflammation and deep PD. Therefore, we did not distinguish peri-implant mucositis and peri-implantitis that were diagnosed by measuring bone level on radiograph in the present pilot study. Biomarkers for BL may be more accurate than clinical BL indicators because PICF NTx amounts were found to correlate with BL rates determined by Schei et al.’s method (ρ = 0.570, P < 0.001). Biomarkers for bone metabolism in PICF and clinical, radiological assessment of bone level may accurately diagnose peri-implant mucositis and peri-implantitis.
Bone-related proteins including ICTP, osteocalcin (OCN), and RANKL have been studied as BL biomarkers in peri-implantitis. ICTP, a cross-linked C-telopeptide of type I collagen, is a marker for bone degradation, and its levels in PICF were significantly higher from peri-implantitis sites than from healthy sites [9, 42]. However, Tümer et al. [13] did not detect a significant difference in PICF ICTP levels between peri-implantitis and healthy sites. RANKL is a main mediator of osteoclast formation and associated with bone resorption [43]. Soluble RANKL (sRANKL) concentrations in PICF were significantly higher from peri-implantitis sites than from healthy implant sites (P < 0.01), and its levels correlated with clinical indicators such as PD (ρ = 0.309, P = 0.034) and BOP (ρ = 0.327, P = 0.024) [44]. In the present study, NTx amounts and concentrations showed similar significant differences to sRANKL between the peri-implant disease and healthy groups (amount: P < 0.01, concentration: P < 0.05), and a stronger correlation was observed between NTx amounts and PD (ρ = 0.434, P < 0.001). In contrast, Arikan et al. [9] showed that sRANKL concentrations in PICF were significantly higher in healthy groups, while Sarlati et al. [45] reported no significant difference in PICF sRANKL concentrations among healthy, peri-implant mucositis, and peri-implantitis groups. OCN is a major non-collagenous protein in bone and is associated with bone metabolism [46]. The mean OCN concentration in PICF from peri-implantitis sites was approximately 1.5-fold that of healthy groups [13], and this finding was similar to the result for NTx in PICF. Although OCN levels in PICF samples were significantly higher from peri-implant mucositis sites without BL than from healthy sites, OCN levels in PICF from peri-implantitis with BL was not significantly different from those in PICF from healthy and peri-implant mucositis sites [47]. These conflicting findings do not necessarily suggest that ICTP, sRANKL, and OCN are reliable biomarkers for alveolar BL. Few studies showed a relationship between the PICF levels of bone-related markers and those of clinical indicators for alveolar BL. NTx levels in GCF samples were significantly higher from periodontitis sites than from healthy sites [28]; however, the relationship between NTx levels in PICF or GCF and BL levels has not yet been investigated. NTx in PICF may be a reliable biomarker for evaluating BL in peri-implantitis because PICF NTx levels correlated with the BL rate as well as PD and had high sensitivity and specificity for predicting peri-implant diseases.
Serial posts:
- Abstract : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [1]
- Abstract : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [2]
- Background : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [1]
- Background : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [2]
- Methods : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [1]
- Methods : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [2]
- Methods : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [3]
- Results : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Discussion : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [1]
- Discussion : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [2]
- Discussion : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [3]
- Conclusions : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Notes : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- References : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [1]
- References : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [2]
- References : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [3]
- References : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [4]
- References : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [5]
- Acknowledgements : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Author information : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [1]
- Author information : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles [2]
- Ethics declarations : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Rights and permissions : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- About this article : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Table 1 One-way ANOVA variance and Tukey’s post hoc test values of removal torque (N cm), removal energy [N cm/rad (0.01 J)], and connection stiffness [N cm/rad] for SAE-HD and SAE implants at 2 and 4 weeks postoperatively (n = 6; P < 0.05) : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Table 2 Spearman rank correlation coefficient values between removal torque (N cm), removal energy [N cm/rad (0.01 J)], and connection stiffness [N cm/rad] for SAE-HD and SAE implants at 2 and 4 weeks postoperatively (n = 6; P < 0.01) : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant surface: an experimental study in Beagles
- Fig. 1. Two pairs of implants (10 mm × 4 mm, L × Ø) from each of the experimental groups were placed in each tibia with an alternating fashion in terms of medio-distal positioning regarding the group, but with the first group chosen at random. Implants were placed with an inter-implant distance of 1 cm : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant
- Fig. 2. Adaptation of Shimadzu universal testing machine for performing removal torque test of dental implants. a General view. b Assembly detail of connection between Allen keys socket and the implant placed in the tibia : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant
- Fig. 3. Representative curve of the torque test for implants. a Graph of torque versus angular displacement with linear regression curve, and equation, representing the connection stiffness. b Determination procedure of unscrewing implant work up to test’s maximum torque : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant
- Fig. 4. Comparison among secant and tangent methods to calculate the connection stiffness values, which reveals the absence of mathematical discrepancy : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant
- Fig. 5. Mean and standard deviation of the biomechanical data at both observation periods (P > 0.05). a Removal torque. b Removal energy. c Connection stiffness : Interfacial biomechanical properties of a dual acid-etched versus a chemically modified hydrophilic dual acid-etched implant
- Abstract : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- Background : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [1]
- Background : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
- Methods : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [1]
- Methods : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
- Results : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [1]
- Results : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
- Discussion : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [1]
- Discussion : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
- Discussion : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [3]
- Conclusions : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- Abbreviations : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [1]
- References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
- References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [3]
- References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [4]
- References : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [5]
- Acknowledgements : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- Author information : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [1]
- Author information : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study [2]
- Ethics declarations : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- Rights and permissions : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- About this article : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- Table 1 Characteristics of participants and examining sites : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant sites with peri-implant diseases: a pilot study
- Fig. 1. Comparison of calprotectin levels in PICF. PICF samples were collected from peri-implant disease sites (n = 40, diseased) and non-diseased sites (n = 34, healthy). Calprotectin amounts (a) were measured by ELISA, and its concentration (b) was normalized by the volume of PICF. Horizontal bars show the mean values of each group. *P < 0.01 : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant
- Fig. 2. Comparison of NTx levels in PICF. NTx amounts (a) in PICF samples from peri-implant disease sites (n = 40, diseased) and non-diseased sites (n = 34, healthy) were measured by ELISA, and its concentration (b) was normalized by the volume of PICF. Horizontal bars show the mean values of each group. ‡P < 0.05, *P < 0.01 : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant
- Fig. 3. Relationship between PICF calprotectin amounts and PD or GI scores. a The relationship between PICF calprotectin amounts and PD was evaluated in PICF samples from peri-implant disease and healthy groups (n = 74, ρ = 0.709, P < 0.001). b Relationship between PICF calprotectin amounts and GI scores. Calprotectin amounts in PICF samples from sites with GI-0 (n = 34), GI-1 (n = 20), and GI-2 (n = 20) were statistically analyzed. Horizontal bars show the median of each group. †P < 0.001 : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant
- Fig. 4. Correlation between NTx amounts and PD or BL rates. a The correlation between PICF NTx amounts and PD was evaluated in PICF samples from peri-implant disease and healthy groups (n = 74, ρ = 0.434, P < 0.001). b The correlation between PICF NTx amounts and BL rates (%) was evaluated in PICF samples from peri-implant disease and healthy groups (n = 74, ρ = 0.570, P < 0.001) : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant
- Fig. 5. ROC analyses of PICF calprotectin and NTx to predict peri-implant diseases. PICF samples were collected from sites with and without peri-implant diseases (n = 74). Calprotectin (a) and NTx (b) amounts in PICF samples were subjected to ROC curve analysis. AUC values for calprotectin and NTx amounts were 0.964 (95% CI = 0.913–0.996, P < 0.001) and 0.784 (95% CI = 0.672–0.891, P < 0.001), respectively, when cutoff values were 60.4 ng/site (arrow in a) and 1.88 ng/site (arrow in b) : Calprotectin and cross-linked N-telopeptides of type I collagen levels in crevicular fluid from implant